LIVE शनिवार, 10 अक्टूबर 2026
BREAKING
Business & Economy

CCI has approved the acquisition of sole control over Omega-Mayer Limited and Mayer Organics by BCPE Wellbeing Holdco Two Limited and Integral Investments Asia IV Limited.

The acquirers, BCPE Wellbeing Holdco Too Limited and Integral Investments Asia IV Limited, are funds managed/advised by Bain Capital
सीसीआई ने बीसीपीई वेलबीइंग होल्डको टू लिमिटेड और इंटीग्रल इन्वेस्टमेंट्स एशिया आईवी लिमिटेड द्वारा ओमेगा-मेयर लिमिटेड और मेयर ऑर्गेनिक्स पर एकमात्र नियंत्रण के अधिग्रहण को मंजूरी दे दी है।
Representative image

Source: Press Information Bureau (PIB), Government of India — Competition Commission of India · PIB Delhi · Read the original release on pib.gov.in

  • The acquirers, BCPE Wellbeing Holdco Too Limited and Integral Investments Asia IV Limited, are funds managed/advised by Bain Capital

The Competition Commission of India (CCI) has approved the acquisition of sole control over Omega-Meyer Limited and Meyer Organics Private Limited by BCPE Wellbeing Holdco Two Limited and Integral Investments Asia IV Limited. These are funds managed and/or advised by Bain Capital.

Proposed Combination Omega-Meyer Limited ( sion target ) and Mayer Organics Pvt Ltd ( mayor target ) which is the owner and controller of a group of companies and affiliated companies doing business as ‘Vitabiotics’ and ‘Mayer Organics’ respectively and the acquisition by Bain Capital Investors, LLC ( By funds managed and/or advised by Bain Capital) BCPE Wellbeing Holdco Two Limited ( acquirer 1 ) and Integral Investments Asia IV Limited ( acquirer 2 ) is being done through.

Bain Capital is a US-based private equity investment firm that invests in companies across multiple industries, including information technology, healthcare, retail and consumer products, communications, financial services, and industrial/manufacturing.

Targeted companies are engaged in supplying nutraceuticals globally and also in India. Meyer Organics Private Limited is also present in the production and supply of some over-the-counter and prescription ready-to-dose drugs in India.

This is the official press release issued by the Press Information Bureau (PIB), and is published without changes.

Source

Official press release issued by the Press Information Bureau (PIB), Government of India — भारतीय प्रतिस्पर्धा आयोग, PIB Delhi. Reproduced as issued, with acknowledgement, under PIB's copyright policy.

View original release
Share this story & connect with us: